This study was undertaken to investigate the effects of the potassium-retaining diuretic, amiloride, on the potassium balance and on the alkalosis which occurs in patients after open-heart surgery.
This small dose of amiloride also appeared to have some effect in reducing the alkalosis. It is concluded that amiloride is a potentially useful drug after cardiac surgery.
Metabolic alkalosis and hypokalaemia are common after open-heart surgery. The former is thought to be due mainly to the transfusion of acid-citratedextrose blood, the citrate being metabolized to bicarbonate. It may also be partly due to hyperventilation (Bain et al., I966; Grigor, I968) . The hypokalaemia has been attributed to long-term diuretic therapy especially in patients who have valve replacement operations. This has been shown to lead to a depletion in the total body potassium despite a normal plasma level and oral potassium supplements (Mandal, Callaghan, and Sterns, I968; Ebert, Jude, and Gaertner, I965; Lockey et al., I966) . The copious diuresis which occurs as a part of postoperative management accentuates the hypokalaemia, and the importance of adequate potassium supplementation in this situation has been emphasized by several authors (Kettlewell, White, and Saunders, I970; Breckenridge et al., I972; Barnard et al., I966; Shanahan, Anderson, and Morris, I969) .
Amiloride is a mild oral diuretic which has potassium retaining properties (Martindale, I972) . Its exact mode of action is uncertain, but it is not a carbonic anhydrase inhibitor, nor an aldosterone antagonist (Baer et al., 1967 ). It appears to act on the distal tubular cells of the nephron, preventing the secretion of potassium, and enhancing the excretion of sodium and bicarbonate (Guignard and Received 29 January 1974. Peters, 1970; Baba et al., I968; Bull and Laragh, I968) . It has been used both to correct the hypokalaemic alkalosis induced by the more powerful diuretics (Antcliffe et al., I97I) and in an attempt to conserve potassium before cardiac surgery (Singh, Hurley, and North, I969) .
This study was mounted to assess its value after cardiac surgery.
Subjects and methods
All patients who underwent valve replacement operations in this unit between i January I973 and 31 July 1973 are included, except for those who had isolated aortic valve replacements who had not been taking diuretics before operation as it was found that they did not usually require postoperative diuretic therapy. Twenty-six patients were studied in all. They were divided into 3 groups, according to the number of valves they had had replaced. Within each group they were paired in chronological order and, using random number tables, one patient from each pair received io mg amiloride daily from the third postoperative day onward. Amiloride is an oral preparation and could not be administered until oral feeding had been established. Fourteen patients acted as controls (C) and I2 received amiloride (A).
Twenty-four hour urine collections were made and arterial blood samples taken on the 3rd, 4th, 7th, and i4th postoperative days. The urine was collected in bottles containing 5o ml toluene, o05 g streptomycin, and 250 mg chloramphenicol, and was kept refrigerated at 40C until it could be analysed. Sodium, potassium, 
difference between them is that the mean age of the amiloride patients is higher than that of the controls. In calculating the mean dose of diuretic, only frusemide was taken into consideration as this was the predominant diuretic used throughout. Though the difference is not significant, it should be noted that the amiloride group received, on average, 48-8I mg more frusemide in the first two postoperative days than did the control group. One patient in this group was also given IOO mg ethacrynic acid, which increases the difference between the groups. The specimens on day 3 were all obtained before any amiloride had been administered.
All the patients tolerated amiloride well and no side effects were seen.
Effect of amiloride on the Pco2, pH, and base excess Amiloride had no effect on the Pco2. The pattern of change in the base excess was not greatly affected by amiloride. Fig. i depicts the change in blood pH. On days 4 and I4 the blood of the control group was significantly more alkaline than that of the amiloride group (P < 0-02 and P < o0os, respectively).
Effect of amiloride on the urinary pH, titratable acidity, ammonium, and hydrogen ion excretion There was no statistically significant difference between the two groups with respect to any of these parameters. The hydrogen ion excretion was calculated as the sum of the titratable acidity and ammonium excretion (Keele and Neil, I97I) and it fell slightly on days 4 and 7.
Effect of amiloride on plasma and urinary sodium, potassium, and chloride The plasma sodium in the control patients started at a slightly higher level than in the amiloride patients, and remained so throughout. This difference was not significant. The urinary sodium is shown in Fig. 2 . The excretion of sodium was greater in the amiloride patients than in the controls on days 3, 4, and 7, but was significantly so only on day 7 (P < oso5). By day I4 the excretion was the same in both groups. Plasma potassium was slightly lower on day 3 in the amiloride group, but on days 4, 7, and I4 it was higher than in the control group (Fig. 3) . The difference was significant at the o0os level on days 4 and 7.
There was no significant difference between the urinary potassium in the two groups before amiloride was started on day 3. Subsequently, however, the amiloride patients excreted considerably less potassium than the controls (P <002, P <ooi, and P<o0o5 on days 4, 7, and 14, respectively) (Fig. 4) . ------C:
F I G. 2 Sodium excretion ( ± standard deviation).
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No difference between the groups was seen with either plasma or urinary chloride.
Effect of amiloride on fluid balance and drug therapy The fluid balance in the two groups was essentially the same. However, the patients given amiloride required less frusemide than the control group from day 8 onwards, the P values being less than o os on days, 8, 9, Ii, and 13, when frusemide alone is considered. Fig. 5 shows the mean dose of potassium supplement required by the two groups. From day 5 onward the amiloride patients needed strikingly less potassium than did the control patients (P < o.oos on days 5 and 7, and P < o.ooi on day 6 and from day 8 to I4). This is much greater than would be accounted for by the difference in the dosage of frusemide.
There was no significant difference in the dose of digoxin received by the two groups.
Effect of amiloride on total exchangeable body potassium No significant difference was found in the KE between patients who had received amiloride and those who did not, but the number of patients in whom the KE was measured was small. Singh et al.
(I969) found little difference in the KE of their patients over a two-week period and concluded that this length of time was too short for a significant difference to occur.
POTASSIUM SUPPLEMENTATION

Discussion
The mode of action of amiloride on the distal tubule of the kidney is uncertain. However, Guignard and Peters (1970) suggest that it prevents the excretion of potassium from the cells and also inhibits the uptake of sodium by acting on the luminal membrane causing it to become impermeable to these ions. This leads to retention of potassium and to a natriuresis. The excretion of hydrogen ions is simultaneously decreased because of the inactivity of the transport mechanism at the luminal border of the cell.
After open-heart surgery, though the patients are alkalotic, they excrete an acid urine. This may be attributed to the exchange of intracellular potassium for extracellular hydrogen and sodium ions. The potassium is excreted, leading to a depletion in the total body content of this ion (Jamieson and Kay, I965) . There is a higher concentration of hydrogen ion in the cell as a result of this interchange, and it has been postulated that it is the low intracellular pH of the tubular cells which is responsible for the secretion of an acid urine (Grigor, I968; Adler, I971) . Bull and Laragh (I968) showed that amiloride caused an increase in the excretion of bicarbonate in conjunction with the natriuresis (Baer et al., I967 ).
In the situation described, amiloride would, therefore, be expected to lead to the following: a rise in plasma and total body potassium, with a fall in potassium excretion. Plasma sodium, blood pH, and hydrogen ion excretion would fall and sodium excretion in the urine would rise.
A pronounced effect was seen on the potassium balance. The amiloride patients required much less potassium supplementation than did the control patients, and yet maintained their plasma potassium levels well above those of the controls. This was due to a significant decrease in the urinary excretion of potassium.
The plasma sodium of the amiloride group began and remained lower than that of the control group, but never significantly so. The lower value would be expected as a result of the natriuretic properties of amiloride. The increased excretion of sodium was confirmed on day 7 but it was the same in both groups on day I4. However, the sodium/potassium ratio in the urine was significantly different between the two groups on both days 7 and 14.
The 
